Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04789408
Title Study Evaluating the Safety of KITE-222 in Participants With Relapsed/Refractory Acute Myeloid Leukemia
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Gilead Sciences
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA

Facility Status City State Zip Country Details
Stanford Cancer Center Stanford California 94305 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
The Ohio State University Wexner Medical Center/James Cancer Hospital Columbus Ohio 43210 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Fred Hutchinson Cancer Center Seattle Washington 98109 United States Details
Institut Paoli-Calmettes Marseille 13009 France Details
CHU de Toulouse Institut Universitaire du Cancer Toulouse Oncopole Toulouse 3110 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field